Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
A Republican elected governor in California? It's not as far-fetched as it sounds. - 2Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
- 3They died 'doing what they loved': The stories of workers in their 80s who died on the job
- 4Virtual reality opens doors for older people to build closer connections in real life
- 5ByHeart infant formula recall tied to botulism outbreak puts parents on edge
- Nodding off is dangerous. Some animals have evolved extreme ways to sleep in precarious environments
- A definitive Burger Confrontation: Which One Rules?
- Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?
- From Loner to Force to be reckoned with: Individual Accounts of Change
- The most effective method to Decide the Best Auto Crash Attorney for Your Lawful Necessities
- 7 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times
- Toilet rats? Washington health officials warn of possible rodents in sewer systems after floods
- VPN Administrations for Online Protection
- Why screening for the deadliest cancer in the U.S. misses most cases
